SEC Form 4 · accession 0001104659-18-042310

Aptinyx Inc. · APTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director · 10% Owner

Period of report

Jun 25, 2018

Accepted (ET)

Jun 26, 2018 · 4:54 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001674365

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Jun 25, 2018	C	1,047,450	—	A	1,047,450	I	See Footnote
Common Stock^F1,F2	Jun 25, 2018	C	1,197,076	—	A	2,244,526	I	See Footnote
Common Stock^F1,F2	Jun 25, 2018	C	795,553	—	A	3,040,079	I	See Footnote
Common Stock^F3,F2	Jun 25, 2018	P	150,000	$16.00	A	3,190,079	I	See Footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Series A-1 Convertible Preferred Stock^F1,F2	—	Jun 25, 2018	C	28,895,188	D	—	—	Common Stock	1,047,450	I
Series A-2 Convertible Preferred Stock^F1,F2	—	Jun 25, 2018	C	33,022,786	D	—	—	Common Stock	1,197,076	I
Series B Convertible Preferred Stock^F1,F2	—	Jun 25, 2018	C	21,946,301	D	—	—	Common Stock	795,553	I

F1Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.
F2The shares are held directly by Frazier Life Sciences VIII, L.P. ("FLS-VIII"). FHM Life Sciences VIII, L.P. ("FHM-VIII L.P.") serves as the sole general partner of FLS-VIII and owns no shares directly. FHM Life Sciences VIII, LLC ("FHM-VIII LLC") serves as the sole general partner of FHM-VIII L.P. and owns no shares directly. James N. Topper and Patrick Heron are members of FHM-VIII LLC and share voting and dispositive power over the shares held by FLS-VIII; however, they disclaim beneficial ownership of the shares held by FLS-VIII except to the extent of their pecuniary interests therein.
F3On June 25, 2018, FLS-VIII purchased 150,000 shares of common stock of the Issuer at a price of $16.00 per share pursuant to an underwritten public offering.

The Reporting Person will no longer be a 10% reporter but will continue to be a director reporter.